| scholarly article | Q13442814 |
| P50 | author | Jaejun Shim | Q81688865 |
| Yong-Han Paik | Q87569659 | ||
| Moon Seok Choi | Q88939412 | ||
| Jung-Hwan Yoon | Q39903625 | ||
| Won Young Tak | Q43284953 | ||
| Dae Won Jun | Q38360840 | ||
| P2093 | author name string | Oh Sang Kwon | |
| Moon Young Kim | |||
| Seung Up Kim | |||
| Hyung Joon Kim | |||
| Dong Joon Kim | |||
| Joo Hyun Sohn | |||
| Hong Soo Kim | |||
| Jae Young Jang | |||
| Sang Gyune Kim | |||
| Se Jin Jang | |||
| Soung Won Jeong | |||
| Young Seok Kim | |||
| Jin Woo Lee | |||
| Ki Tae Suk | |||
| Soon Koo Baik | |||
| Young Bae Kim | |||
| Seong Gyu Hwang | |||
| Byung Seok Lee | |||
| Jae Youn Cheong | |||
| Sung Won Cho | |||
| Yong Kyun Cho | |||
| Jae Geun Kim | |||
| Hyun Woong Lee | |||
| Ja Kyung Kim | |||
| Young Kul Jung | |||
| Jin Young Choi | |||
| Won Hyeok Choe | |||
| June Sung Lee | |||
| In Hee Kim | |||
| Dae Hee Choi | |||
| Si Hyun Bae | |||
| Gab Jin Cheon | |||
| Yeon Seok Seo | |||
| Woo Jin Chung | |||
| Byoung Kuk Jang | |||
| Chang Hyeong Lee | |||
| Korean Association for the Study of the Liver | |||
| P2860 | cites work | Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial | Q82824347 |
| Independent effects of physical activity in patients with nonalcoholic fatty liver disease | Q83836979 | ||
| Management of adult patients with ascites due to cirrhosis: an update | Q83932911 | ||
| Cirrhosis: diagnosis with sonographic study of the liver surface | Q93514132 | ||
| Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review | Q22242709 | ||
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis | Q24625697 | ||
| Guidelines on the management of ascites in cirrhosis | Q24676541 | ||
| “Mini-mental state” | Q25938989 | ||
| Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon | Q27487518 | ||
| Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial | Q28139961 | ||
| Neuropsychological characterization of hepatic encephalopathy | Q28204449 | ||
| Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial | Q28239982 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis | Q28244261 | ||
| Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis | Q28248518 | ||
| Telbivudine versus lamivudine in patients with chronic hepatitis B | Q28261708 | ||
| Rifaximin treatment in hepatic encephalopathy | Q28277660 | ||
| The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy | Q28290221 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| Liver fibrosis | Q29547449 | ||
| Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. | Q31166704 | ||
| Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials | Q33200604 | ||
| Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis | Q33375742 | ||
| Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study | Q33628162 | ||
| Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study. | Q33781627 | ||
| Pharmacological treatment of portal hypertension: an evidence-based approach | Q33822133 | ||
| The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study. | Q46771214 | ||
| Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study | Q46929734 | ||
| Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. | Q46948629 | ||
| A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. | Q46981468 | ||
| Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C. | Q50571468 | ||
| Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study. | Q50571679 | ||
| Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. | Q51558596 | ||
| Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. | Q51575245 | ||
| Hepatic Encephalopathy. | Q52887128 | ||
| Cirrhosis: modified caudate-right lobe ratio. | Q52942476 | ||
| Probiotic yogurt for the treatment of minimal hepatic encephalopathy. | Q53134638 | ||
| Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. | Q53407925 | ||
| Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. | Q53506301 | ||
| Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. | Q53592212 | ||
| Hyponatremia in cirrhosis: Results of a patient population survey. | Q53805992 | ||
| Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding | Q38574489 | ||
| A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). | Q39443657 | ||
| Safety of oral intake of vitamin E. | Q39520344 | ||
| Pentoxifylline: a first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome? | Q39965729 | ||
| Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. | Q40580137 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Manganese and chronic hepatic encephalopathy | Q41678344 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club | Q33836637 | ||
| Effect of propranolol on portal pressure and systemic hemodynamics in patients with liver cirrhosis and portal hypertension: a prospective study | Q33855738 | ||
| Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis | Q33869859 | ||
| Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial | Q33903205 | ||
| A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices | Q33945950 | ||
| Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study | Q33958028 | ||
| Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. | Q33961582 | ||
| The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club | Q33966809 | ||
| Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome | Q33979654 | ||
| Which patients benefit from hemodialysis therapy in hepatorenal syndrome? | Q33983917 | ||
| Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome | Q34002050 | ||
| Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. | Q34011626 | ||
| Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club | Q34062215 | ||
| Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis | Q34111213 | ||
| Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. | Q34116455 | ||
| Prediction of variceal hemorrhage by esophageal endoscopy | Q34274411 | ||
| Salvage therapies for refractory variceal hemorrhage | Q34374939 | ||
| Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. | Q34469981 | ||
| Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. | Q34500537 | ||
| Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis | Q34503648 | ||
| Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding | Q34508947 | ||
| Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial | Q34510409 | ||
| Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. | Q34521372 | ||
| A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices | Q34523064 | ||
| Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. | Q34526007 | ||
| Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial | Q34529788 | ||
| Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death | Q34551093 | ||
| Lamivudine for patients with chronic hepatitis B and advanced liver disease | Q34551713 | ||
| Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial | Q34555329 | ||
| Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison | Q34555615 | ||
| Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy | Q34576485 | ||
| A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis | Q34585893 | ||
| Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience | Q42042704 | ||
| Restricted use of albumin for spontaneous bacterial peritonitis | Q42843083 | ||
| High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial | Q42947254 | ||
| Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. | Q42947269 | ||
| Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy | Q42979108 | ||
| A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia | Q42995701 | ||
| Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection | Q43090210 | ||
| Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico. | Q43258562 | ||
| Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis | Q43290751 | ||
| Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients | Q43468934 | ||
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid | Q43483632 | ||
| Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. | Q43588019 | ||
| Terlipressin and albumin combination treatment in hepatorenal syndrome. | Q43666089 | ||
| Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension | Q43703959 | ||
| Metformin in non-alcoholic steatohepatitis. | Q43745120 | ||
| Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years | Q43914060 | ||
| Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study | Q43974544 | ||
| Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study | Q44080043 | ||
| Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2. | Q44240609 | ||
| Histological outcome during long-term lamivudine therapy. | Q44269261 | ||
| Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases | Q44324874 | ||
| Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety | Q44520887 | ||
| Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone | Q44598595 | ||
| Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. | Q44632315 | ||
| Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis | Q44668896 | ||
| The clinical usefulness of balloon occluded retrograde transvenous obliteration in gastric variceal bleeding | Q44706291 | ||
| Therapeutic effect of the endoscopic N-butyl-2-cyanoacrylate injection for acute esophagogastric variceal bleeding: comparison with transjugular intrahepatic portosystemic shunt | Q44807696 | ||
| A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis | Q44907394 | ||
| Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study | Q45003218 | ||
| Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis | Q45728732 | ||
| Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. | Q45917916 | ||
| Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. | Q45927000 | ||
| Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. | Q45943514 | ||
| Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. | Q45990341 | ||
| Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans | Q46123514 | ||
| Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. | Q46217486 | ||
| Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding | Q46397568 | ||
| The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites | Q46397598 | ||
| Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. | Q46408081 | ||
| Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis | Q46415674 | ||
| Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis | Q46418008 | ||
| Clinical experience of endoscopic banding ligation for bleeding gastric varices. | Q46493675 | ||
| Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study | Q46545710 | ||
| Circulatory function and hepatorenal syndrome in cirrhosis. | Q46565582 | ||
| Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy | Q46630202 | ||
| Acetyl-L-carnitine treatment in minimal hepatic encephalopathy | Q46689540 | ||
| Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis. | Q46732704 | ||
| Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension | Q34621625 | ||
| Somatostatin and analogues in portal hypertension. | Q34656371 | ||
| Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis | Q34690306 | ||
| Risk factors for hemorrhage from gastric fundal varices | Q34737844 | ||
| Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome | Q34950855 | ||
| Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. | Q34973715 | ||
| Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo | Q34985317 | ||
| Analogs and fibrosis regression in hepatitis B. | Q34994682 | ||
| Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. | Q35068045 | ||
| Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study | Q35360714 | ||
| Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding | Q35612425 | ||
| Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial | Q35681885 | ||
| Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990 | Q35739188 | ||
| Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | Q35833031 | ||
| The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension | Q36014521 | ||
| Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding | Q36041168 | ||
| Variceal bleeding: pharmacological therapy. | Q36141427 | ||
| Endoscopic band ligation in the treatment of portal hypertension | Q36342341 | ||
| Noninvasive measures of liver fibrosis | Q36382285 | ||
| Review article: Management of ascites and associated complications in patients with cirrhosis | Q37032763 | ||
| A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome | Q37061659 | ||
| The management of ascites and hyponatremia in cirrhosis | Q37091925 | ||
| Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis | Q37096330 | ||
| Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt | Q37231675 | ||
| Effects of weight loss on nonalcoholic fatty liver disease | Q37310307 | ||
| Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program | Q37489472 | ||
| Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials | Q37565848 | ||
| Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients | Q37688224 | ||
| Management of varices and variceal hemorrhage in cirrhosis | Q37702063 | ||
| Pharmacotherapy for hepatic encephalopathy | Q37762245 | ||
| Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver | Q37769273 | ||
| EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis | Q37773059 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| The Clinical Course of Patients with Type 1 Hepatorenal Syndrome Maintained on Hemodialysis | Q54989557 | ||
| [Etiologic and laboratory analyses of ascites in patients who underwent diagnostic paracentesis]. | Q55044107 | ||
| Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: | Q56925418 | ||
| Optimum use of diuretics in managing ascites in patients with cirrhosis | Q56989437 | ||
| Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices: Results of a Multicenter, Prospective, Validation Study | Q57168227 | ||
| Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver | Q57749807 | ||
| Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis | Q57782884 | ||
| Compensated cirrhosis: Natural history and prognostic factors | Q57942626 | ||
| Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems | Q61576536 | ||
| Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content | Q61763120 | ||
| What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy | Q63278165 | ||
| Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation | Q71129737 | ||
| Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis | Q71170170 | ||
| Ethanolamine Oleate Versus Butyl Cyanoacrylate for Bleeding Gastric Varices: a Nonrandomized Study | Q71813316 | ||
| Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites | Q73322900 | ||
| Ascites | Q73571408 | ||
| Prevention of variceal rebleeding | Q73615186 | ||
| Lactic acidosis in patients with diabetes treated with metformin | Q74085124 | ||
| Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety | Q74097977 | ||
| Subclinical hepatic encephalopathy impairs daily functioning | Q74764249 | ||
| Portal hypertension and variceal bleeding: an AASLD single topic symposium | Q77220747 | ||
| Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy | Q77320767 | ||
| Gastric variceal ligation: a new technique | Q77320772 | ||
| Retrograde transvenous obliteration of gastric varices | Q77400812 | ||
| Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when | Q77474206 | ||
| Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing | Q77530317 | ||
| Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance | Q79621925 | ||
| Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study | Q79765130 | ||
| [Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in the treatment of gastric varices in cirrhotic patients with gastrorenal shunt] | Q79805709 | ||
| Value of the critical flicker frequency in patients with minimal hepatic encephalopathy | Q80060307 | ||
| [Effect of endoscopic sclerotherapy using N-butyl-2-cyanoacrylate in patients with gastric variceal bleeding] | Q80336170 | ||
| Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease | Q80372779 | ||
| [Long-term results of endoscopic histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices--a 10-year experience] | Q80382427 | ||
| Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome | Q81037349 | ||
| Current management of portal hypertension | Q81151967 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | liver cirrhosis | Q147778 |
| P304 | page(s) | 1-21 | |
| P577 | publication date | 2012-03-22 | |
| P1433 | published in | The Korean journal of hepatology | Q27720798 |
| P1476 | title | Revision and update on clinical practice guideline for liver cirrhosis | |
| P478 | volume | 18 |
| Q37586263 | 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy |
| Q38419592 | Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma. |
| Q57112615 | Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis |
| Q99555523 | Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding |
| Q40512420 | Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer |
| Q34255479 | Alcoholic liver disease: treatment |
| Q44466854 | Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. |
| Q34359354 | Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. |
| Q35898936 | Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition. |
| Q37522665 | Clinical features of acute hepatitis E super-infections on chronic hepatitis B. |
| Q36518878 | Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study |
| Q87660536 | Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis |
| Q36837572 | Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding |
| Q39232902 | Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites |
| Q33576986 | Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial. |
| Q92484973 | Current approaches to the management of patients with cirrhotic ascites |
| Q38215498 | Cyanoacrylate injection compared with band ligation for acute gastric variceal hemorrhage: a meta-analysis of randomized controlled trials and observational studies. |
| Q35551316 | Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy |
| Q47163223 | Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up. |
| Q41070567 | Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients |
| Q54247054 | Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D. |
| Q48136392 | Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B. |
| Q33853205 | Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era. |
| Q36418673 | Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis |
| Q45734844 | Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage |
| Q50894482 | Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. |
| Q47296990 | Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study |
| Q41653263 | Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment |
| Q49171086 | Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection |
| Q59133437 | Iron metabolism disorders in patients with hepatitis B-related liver diseases |
| Q89502154 | KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications |
| Q92522263 | KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications |
| Q64897844 | KASL clinical practice guidelines for management of chronic hepatitis B. |
| Q33872993 | Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues |
| Q38611499 | Liver cirrhosis caused by chronic Budd-Chiari syndrome |
| Q61811338 | Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model |
| Q42559530 | Long-term suppression of viral replication in chronic hepatitis B: outcomes and future directions. |
| Q38433971 | Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin |
| Q88881070 | Nutrition principles and recommendations in different types of hepatic encephalopathy |
| Q39842685 | Prevention and management of variceal hemorrhage |
| Q38810558 | Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma |
| Q35826267 | Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma |
| Q38405406 | Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma. |
| Q36653675 | Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation: A Retrospective Cohort Study |
| Q39051404 | Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis. |
| Q89448325 | Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose |
| Q37213570 | Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease |
| Q37622223 | Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease |
| Q92855314 | Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis |
| Q34208316 | Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites |
| Q34779739 | Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B. |
| Q41857211 | Spontaneous bacterial peritonitis with sepsis caused by Enterococcus hirae |
| Q39616292 | Spontaneous healing of gastric perforation after endoscopic ligation for gastric varices |
| Q38426156 | The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients |
| Q92765073 | The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients |
| Q59353649 | The changing epidemiology of liver diseases in the Asia-Pacific region |
| Q35231817 | The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B. |
| Q41384462 | The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years? |
| Q30741669 | The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data |
| Q58121632 | Towards quantitative quasi-static ultrasound elastography using a reference layer for liver imaging application: A preliminary assessment |
| Q50236829 | Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial |
| Q37510598 | Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker. |
| Q44998831 | Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation |
| Q49217460 | Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes. |
| Q43089477 | What we know about paracentesis induced circulatory dysfunction? |
Search more.